ArticleBreast cancer research : BCR2026
Predictive performance of breast cancer polygenic risk scores from diverse ancestries: a prospective study in Japanese women.
Article in Breast cancer research : BCR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
Abstract
backgroundPolygenic risk scores (PRSes) have emerged as promising tools for stratifying breast cancer risk on the basis of genomic data. However, PRSes developed in one ancestral population may vary in predictive performance when applied to a different population. This study aimed to evaluate the utility of six breast cancer PRSes developed via European and East Asian genome-wide association studies (GWASes) in a Japanese prospective cohort.
methodsWe analysed data from 7,965 women enrolled in the Japan Multi-Institutional Collaborative Cohort (J-MICC) study, with a mean follow-up of 11.3 years. Six published PRSes were calculated via genome-wide genotype data, and their associations with breast cancer incidence were assessed via Cox proportional hazards models adjusted for age, survey area, and population structure. Hazard ratios (HRs), 95% confidence intervals (CIs), and Harrell’s C statistics are reported.
resultsFive of the six PRSes were significantly associated with breast cancer risk. The European-derived PRS313_BC demonstrated the highest predictive performance (HR per standard deviation (SD) = 1.64; C statistic = 0.69; P < 0.001), particularly among women diagnosed with breast cancer before 50 years of age.
conclusionsDespite cross-ancestry differences, a European-derived PRS demonstrated strong predictive value for breast cancer risk in a Japanese population, likely reflecting the scale and optimization of the original GWAS. These findings indicate that GWAS scale and statistical power may currently outweigh ancestry matching in PRS performance. However, large-scale ancestry-specific GWASes remain essential to improve prediction accuracy in East Asian populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.